First Light Diagnostics

MassDevelopment provided a $2.5 million Emerging Technology Fund loan to First Light Diagnostics, Inc., a Chelmsford company that develops automated medical diagnostic systems for rapid and cost-effective diagnosis and treatment of life-threatening multidrug-resistant infections. First Light Diagnostics is in the late stages of developing its MultiPath™ technology platform, which can perform identification tests within 30 minutes and antimicrobial susceptibility tests within four hours directly from a patient sample without culture. First Light Diagnostics recently closed its Series A-2 round of equity financing, and will use loan proceeds to hire additional full-time employees and expand its capabilities.